European Pharmaceutical Review

JUNE 7, 2024

Pharmaceutical companies ask themselves this question before embracing the latest technologies because every innovation comes with both opportunities and risks. According to recent estimates, the opportunity from generative AI alone could produce up to $110 billion in annual value across the pharmaceutical industry value chain.

Health and Personal Care Stores 113

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Drug Development 113

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

European Pharmaceutical Review

APRIL 3, 2024

Research by Roots Analysis predicts the pharmaceutical contract manufacturing market will value $140 billion by 2030. percent between 2022-2030. The report noted that there has been “considerable” merger and acquisition activity in recent years within the pharmaceutical contract manufacturing market. percent between 2022-2030.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Compounding 52

Pharmaceutical Technology

MAY 30, 2023

The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. This deal follows Abiogen’s recent acquisition of the Cologne, Germany-based Altamedics in December 2022. Alkindi is one of EffRx’s three marketed drugs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals Drug Development 52

European Pharmaceutical Review

FEBRUARY 21, 2023

After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Short discussed the heavy workload involved in navigating the regulations associated with a controlled drug. They are there to do a job and ultimately to keep patients safe.

Pharmaceutical Companies 132

Pharmaceutical Companies Pharmaceutical Companies Compounding Drug Development 132

Pharmaceutical Technology

DECEMBER 9, 2022

Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. Brazilian public spending on healthcare, drug pricing reforms and remote medicine. These treatments may still be in development or already have approval somewhere in the world. </p>

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

pharmaphorum

JULY 15, 2022

Ophthalmic Drugs Conference. 21 – 22 November 2022 | London, UK. SAE Media Group’s 5th Annual Ophthalmic Drugs Conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing good clinical trial data. SAE Media Group’s 5th Annual. And many more!

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

European Pharmaceutical Review

DECEMBER 21, 2022

“As the contribution of costs of organic chemicals used as feedstock to the operating expenditures is small, the pharmaceutical companies can spearhead and guide the transition.” He is currently group leader of the Technology Development and Discovery Group at the Bioprocess Laboratory of the ETH. PNAS 2022, Vol.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

European Pharmaceutical Review

SEPTEMBER 2, 2022

She has worked with regulatory agencies and pharmaceutical companies for over 10 years. Hannah Balfour is the Science Writer for European Pharmaceutical Review. Netherlands Medicines Evaluation Board (CBG-MEB) 2022 [cited June 2022]. US Food and Drug Administration. References. Available from: [link].

Adverse Reactions 96

Adverse Reactions Documentation Medical Schools Packaging 96

PharmaKinnex

APRIL 28, 2022

3 Reasons Why Rare Disease Marketing Strategies Need To Start With Inside Sales April 28, 2022. Over the past few years, rare disease drugs have seen an increase in research and development from the big pharmaceutical companies. The power of inside sales begins here. Territory Warming & Lead Generation.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

European Pharmaceutical Review

JULY 4, 2024

4,6 Five patent issues that European biosimilar developers should consider before entering the US market Quality control of the botanical drug substances was one of the critical factors that led to barricades during the development of Veregen and Mytesi. 2022 [cited 2024May]. BMB Reports. 2017;50(3):111–6.

Drug Development 103

Drug Development Biosimilars Documentation Labelling 103

pharmaphorum

APRIL 19, 2022

In 2022, pharma is truly a global industry, and innovation can come from anywhere. RudaCure is a four-year-old biotech company based in the South Korea, focusing on ocular disease and chronic pain with a pair of potentially first-in-class drugs. Now, the company is trying to make contacts beyond South Korea’s borders.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

Avéma’s team of scientists and manufacturing experts have more than 40 years of Rx formulation development expertise and decades of producing. generic drugs at both small development companies and multinational pharmaceutical companies. ft of manufacturing and R&D space. Continuous investment.

Packaging 59

Packaging Controlled Substances Documentation Pharmaceutical Companies 59

Pharmaceutical Technology

OCTOBER 26, 2022

According to Tufts Center for the Study of Drug Development (CSDD), in a typical Phase Ill clinical trial, 119 protocol deviations are implemented on average, involving approximately one-third of all patients participating in that trial. 1 Tufts Center for the Study of Drug Development (CSDD); Jan/Feb 2022 Impact Report.

Drug Development 52

Drug Development Communication Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JANUARY 13, 2025

Research shows that the overall carbon emissions of the biotechnology sector globally totalled 193 million tCO2-e (tonnes of carbon dioxide equivalent) in 2022. Research shows that the overall carbon emissions of the biotechnology sector globally totalled 193 million tCO2-e (tonnes of carbon dioxide equivalent) in 2022. NHS England.

Packaging 52

Packaging Community Pharmacies Documentation Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 22, 2022

Below you can find all the winners from the 2022 Excellence Awards which celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change. Pfizer wins the M&A award after a string of significant deals were finalised in 2022.

Diabetes 52

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

STAT

DECEMBER 13, 2024

billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022. Just 9% came from the private sector, such as pharmaceutical companies. Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2

Pharmaceutical Companies 250

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Pricing 250

PharmaShots

FEBRUARY 27, 2023

As a renowned chemist, Dr. Senanayake discussed the need to adopt green chemistry in the process of drug development for cost reduction, timely innovation, and generating less waste than the standard process. According to me the main issue faced during the pandemic was the supply chain of pharmaceuticals.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Regulation, particularly Annex 1, was identified as a key focus for 2022.

Vaccines 128

Vaccines Research Laboratories Documentation Compounding 128

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 23 April 2013.

Biosimilars 96

Biosimilars Dosage Drug Pricing Pharmaceutical Companies 96

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. per 100,000 people were hospitalised for RSV-related reasons in the 2022–23 RSV season. per 100,000.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

European Pharmaceutical Review

APRIL 10, 2024

The recent FDA approvals of two microbiome products in the US, in November 2022 and April 2023, 1-2 represent a significant milestone, maturing the industry and paving the way for advancement and regulatory clearance of additional microbiome products in broader indications. Internet] Pharmaceutical Technology. cited 2024Feb].

Immunity 95

Immunity Immunization Chemotherapy Diabetes 95

Pharmaceutical Technology

MAY 17, 2023

The Inflation Reduction Act, which became US law in August 2022, has invited its fair share of critics and supporters over its drug pricing provisions. While negotiating drug prices is common practice in other major markets, CMS had not previously held the legal authority to do so.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Express Pharma

JULY 10, 2024

She also suggests, “India can foster collaboration between the IT and the biopharma companies through government or private initiated collaborative channels – these can help facilitate discussions around latest technological advancements available that could help in overcoming challenges in biopharma drug development and advancement.”

Vaccines 96

Vaccines Drug Development Process Improvement Biosimilars 96

PharmaShots

FEBRUARY 21, 2023

The company is developing PPMX-T002, an anti-cancer drug with an antibody targeting CDH3 connected with a radioisotope yttrium 90 (90Y). Perseus has been discussing the collaborative development of PPMX-T002 with various RI medical drug-developing companies, including PeptiDream and its subsidiary PDRAdhiopharma.

Dosage 56

Dosage Labelling Immunity Immunization 56

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. In addition, in 2022, non-new molecular entity (NME) injectables approvals were the highest they have been for the last decade.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

FEBRUARY 6, 2023

For clinical trials, the Pulse offers researchers and pharmaceutical companies the ability to capture a full suite of vascular biomarkers necessary to characterize the hemodynamic status of clinical trial participants at their homes and transmit the data directly to the study personnel analyzing the impact of intervention being studied.

Health and Personal Care Stores 53

Health and Personal Care Stores Biosimilars HIPAA Pharmaceutical Companies 53

PharmaShots

APRIL 10, 2023

Moreover, the ceaseless trials of pharmaceutical companies in the research of drugs for several disease conditions have transformed the course of therapeutics. It is sold under the brand names Farxiga in the US and Forxiga in the EU.

Diabetes 40

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

DECEMBER 9, 2022

Rankings 2022. M&A – Commended PRODUCT LAUNCHES – Commended RESEARCH AND DEVELOPMENT – Commende d. Pharmaceutical Technology Excellence Rankings – The Verdict. Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing.

Vaccines 52

Vaccines Biosimilars Compounding Packaging 52

Pharmaceutical Technology

FEBRUARY 20, 2023

We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ)

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52

Drug Patent Watch

DECEMBER 11, 2024

This growth has created a competitive landscape where pharmaceutical companies must carefully evaluate and select the right CDMO partner to ensure the success of their projects. Your Drugs Development Stage The stage of your drug development is a critical factor in selecting a CDMO.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 98

STAT

APRIL 8, 2025

The National Security Commission on Emerging Biotechnology was created by Congress in 2022 to explore how biotechnology advancements could shape the economy and national security. biotech intellectual property and bolster drug development, agriculture, and biological weapons defense. Reuters reports.

Pharmaceutical Companies 166

Pharmaceutical Companies Pharmaceutical Companies Drug Development 166

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies have been working on developing vaccines and other prophylactics for respiratory syncytial virus (RSV) since its discovery in 1956. Despite strong efforts and scientific advances, a safe and effective vaccine for RSV has yet to be approved for any patient population.

Vaccines 64

Vaccines Documentation Immunity Immunization 64

European Pharmaceutical Review

FEBRUARY 3, 2025

In recent years, leading pharmaceutical companies, such as Sanofi, successfully launched smart factory programmes. What lessons can you offer to other manufacturers/drug developers? 2022; 78:102828. The Role Of Raman Spectroscopy In Biopharmaceuticals From Development To Manufacturing. 2022; 414(2):969-991.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52